GMP Risk-Based Site Inspection Pilot Will Select Half Of FY ’05 Visits
Executive Summary
The Center for Drug Evaluation & Research's risk-based manufacturing site inspection pilot will be involved in the selection of roughly half of all facilities visited in fiscal year 2005
You may also be interested in...
Horowitz Goes From FDA Office Of Policy To HHS Office Of General Counsel
The departure of FDA Assistant Commissioner for Policy David Horowitz to become a deputy general counsel at the Department of Health and Human Service's Office of General Counsel gives Commissioner Margaret Hamburg the opportunity to further shape the agency's senior staff
Horowitz Goes From FDA Office Of Policy To HHS Office Of General Counsel
The departure of FDA Assistant Commissioner for Policy David Horowitz to become a deputy general counsel at the Department of Health and Human Service's Office of General Counsel gives Commissioner Margaret Hamburg the opportunity to further shape the agency's senior staff
Risk-Based GMPs: FDA Priorities Will Reflect Exposure, Compliance Record
FDA's risk-based inspection model will consider a product's breadth of use when assigning inspection priorities